QNRX·74907L409·US·ADR·Healthcare - Biotechnology-13D/G
QNRX (QUOIN PHARMACEUTICALS LTD) is held by 10 institutional investors as of Q1 2026. Largest holders: Woodline Partners LP ($525,241), MILLENNIUM MANAGEMENT LLC ($503,230), Aberdeen Group plc ($495,000). Net institutional sentiment: Bullish.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer